诺舒阻抗控制子宫内膜切除系统治疗月经过多66例临床分析

摘要

Objective To investigate the efficiency and safety of NovaSure system for menorrhagia .Methods Sixty-six women with menorrhagia received NovaSure system for treatment .The clinical effect and complications were followed up at months 1, 3, 6 and 12.Results The procedures was completed successfully in all the patients .The rate of efficiency was 98.48%, 98.08%, 97.06%, 100.00%respectively at months 1, 3, 6 and 12.And the rate of amenorrhea was 43.94%, 53.85%, 55.88%, 62.50% respectively .There was no significant difference in the rate of efficiency and amenorrhea among 1, 3, 6 and 12 months(P>0.05).No intraoperative or postoperative com-plications occurred .Conclusion NovaSure shows high and stable efficiency and safety .It is worthy of clinical appli-cation.%目的：探讨诺舒阻抗控制子宫内膜切除系统（ NovaSure ）治疗月经过多的有效性及安全性。方法对66例月经过多患者进行NovaSure治疗，术后1、3、6、12个月进行电话随访，观察其疗效及并发症。结果66例均顺利完成手术，术后1、3、6、12个月有效率分别为98.48％、98.08％、97.06％、100.00％，闭经率分别为43.94％、53.85％、55.88％、62.50％，差异均无统计学意义（ P＞0.05）。术中、术后无不良反应发生。结论 NovaSure治疗月经过多疗效好而且稳定，安全性好，值得临床推广应用。